If you liked this article you might like

After Soaring to $150, Can Incyte Stir Up More Upside?
Biotech Movers: Cempra Flys High On Phase Three Results
Kinder Morgan Was the Biggest Energy Beneficiary From the 'Trump Rally'
Cramer: The 10 Biggest Gainers of 2016, and How They Will Fare in 2017